What Healthcare Organizations Must Implement Under the FDA's May 2024 Medical Device Servicing Environment Cybersecurity Guidance

I must note that the sources provided do not contain the FDA's May 2024 Medical Device Servicing Environment Cybersecurity Guidance or any information about its requirements. The supplied sources cover NIST's Cybersecurity Framework, FTC privacy and security topics, and NIST's Privacy Framework—none of which address FDA medical device guidance.

Without access to the actual FDA guidance document or authoritative summaries of its content, I cannot accurately describe what it requires, who it holds accountable, or what implementation steps healthcare organizations must take. Any attempt to do so would require inventing facts not present in the supplied sources, which violates the absolute rules governing this content.

What Would Be Needed

To write this article as briefed, the following sources would be required:

• The FDA's May 2024 guidance document itself, or an official FDA summary
• Any accompanying FDA statements about scope, applicability, and enforcement expectations
• Authoritative interpretation from healthcare regulatory bodies regarding implementation
• Documentation of how this guidance relates to existing frameworks such as NIST CSF 2.0 in healthcare contexts

Why This Matters

Medical device cybersecurity in healthcare delivery environments represents a critical intersection of patient safety, regulatory compliance, and enterprise risk management. Devices that were once isolated now connect to networks, creating paths for both clinical benefit and security risk. Leadership accountability exists regardless of whether clear implementation guidance has been established internally.

The challenge many healthcare organizations face is not whether device security matters, but who owns the coordination between clinical engineering, IT security, network operations, compliance, and executive oversight. Without clear ownership and governance, these responsibilities remain diffuse, progress cannot be measured, and accountability remains theoretical.

Where Virtual CISO Leadership Applies

Regardless of specific FDA guidance, healthcare organizations need executive-level security leadership that can translate regulatory requirements into governance, coordinate cross-functional implementation, make risk-based decisions about device segmentation and monitoring, and report progress to boards and executive teams in business terms.

This is the territory where [virtual CISO leadership](/vciso/) provides value: not as another technical resource, but as the accountable executive who establishes strategy, makes risk decisions, coordinates between functions, and maintains the regulatory posture leadership needs. For medical device security specifically, a vCISO provides the bridge between clinical requirements, technical implementation, and compliance obligations.

What Leadership Should Do

Without the specific FDA guidance in hand, general principles still apply to any medical device security requirement:

• Obtain and review the complete FDA guidance document to understand scope and applicability
• Identify which devices in your environment fall under the guidance and document current state
• Establish clear executive ownership for device security governance—not just technical implementation
• Map current device security practices against guidance requirements to identify gaps
• Determine whether existing leadership has capacity and authority to coordinate implementation across clinical engineering, IT, network operations, and compliance
• Consider whether executive-level security leadership is needed to maintain accountability and regulatory position

If your organization faces accountability for medical device security outcomes without clear ownership or implementation paths, that indicates a governance gap rather than a technical gap. The question is not what tools to deploy, but who owns the decisions, coordinates the work, and reports progress to leadership.

A Confidential Conversation

If your organization is working through medical device security requirements and needs executive-level ownership to coordinate implementation, maintain regulatory position, and report to the board, a confidential consultation with Heights can clarify whether virtual CISO leadership would address the gap. This is not a sales process—it is a conversation about governance, accountability, and what adequate ownership looks like for your situation.

Reach Heights Consulting Group at [email protected].